N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide
![N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide Structure](CAS/20150408/GIF/1346528-50-4.gif)
- CAS No.
- 1346528-50-4
- Chemical Name:
- N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide
- Synonyms
- CS-2830;JNJ42165279;JNJ-42165279 (JNJ-5279);JNJ 42165279;JNJ42165279;JNJ-42165279, 10 mM in DMSO;Fatty acid amide hydrolase,inhibit,Autophagy,JNJ 42165279,FAAH,JNJ-42165279,Inhibitor;N-(4-Chloro-3-pyridinyl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]-1-piperazinecarboxamide;1-Piperazinecarboxamide, N-(4-chloro-3-pyridinyl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]-;N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide
- CBNumber:
- CB32671063
- Molecular Formula:
- C18H17ClF2N4O3
- Molecular Weight:
- 410.8
- MDL Number:
- MFCD29047142
- MOL File:
- 1346528-50-4.mol
- MSDS File:
- SDS
- TDS File:
- TDS
N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide Properties
| Boiling point | 541.2±50.0 °C(Predicted) |
|---|---|
| Density | 1.52±0.1 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | ≤30mg/ml in ethanol;30mg/ml in DMSO;30mg/ml in dimethyl formamide |
| form | crystalline solid |
| pka | 12.91±0.20(Predicted) |
| color | White to off-white |
| FDA UNII | AH2E5UQ11Y |
N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide price More Price(42)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 19987 | JNJ-42165279 ≥98% | 1346528-50-4 | 1mg | $49 | 2026-04-30 | Buy |
| Cayman Chemical | 19987 | JNJ-42165279 ≥98% | 1346528-50-4 | 5mg | $190 | 2026-04-30 | Buy |
| Cayman Chemical | 19987 | JNJ-42165279 ≥98% | 1346528-50-4 | 10mg | $283 | 2026-04-30 | Buy |
| Cayman Chemical | 19987 | JNJ-42165279 ≥98% | 1346528-50-4 | 25mg | $527 | 2026-04-30 | Buy |
| ChemScene | CS-5411 | JNJ-42165279 99.95% | 1346528-50-4 | 5mg | $108 | 2026-06-04 | Buy |
N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide Chemical Properties, Uses, Production
Description
JNJ-42165279 is a potent, irreversible inhibitor of fatty acid amide hydrolase (FAAH; IC50s = 70 and 313 nM for human and rat forms, respectively). It displays selectivity for FAAH over a panel of other enzymes, receptors, transporters, and ion channels. JNJ-42165279 is active in vivo, blocking FAAH activity in brain and periphery of rats and raising concentrations of anandamide , oleoyl ethanolamide , and palmitoyl ethanolamide . It is also efficacious in the spinal nerve ligation model of neuropathic pain.
Uses
JNJ-42165279 is an orally active FAAH inhibitor, with IC50 values of 70 nM for hFAAH and 313 nM for rFAAH. JNJ-42165279 can be used in research related to the field of neuropathic pain[1][2].
Synthesis
20511-15-3
![1-[(2,2-Difluoro-1,3-benzodioxol-5-yl)-Methyl]piperazine](/CAS/GIF/1093211-85-8.gif)
1093211-85-8
1885-14-9
![N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide](/CAS/20150408/GIF/1346528-50-4.gif)
1346528-50-4
3-Amino-4-chloropyridine (35.0 g, 272 mmol) and toluene (740 mL) were added to a 2 L three-necked Morton flask equipped with a mechanical stirrer, thermocouple, and a charging funnel under nitrogen protection. The resulting brown solution was cooled to 2°C. Pyridine (25.3 mL, 310 mmol) was added all at once, followed by the dropwise addition of phenyl chloroformate (32.6 mL, 259 mmol) over a 30-minute period, controlling the reaction temperature to not more than 5°C. After stirring at 2-5 °C for 7 h, the reaction mixture was transformed into a thick yellow suspension. A pre-cooled aqueous solution of K2CO3 (53.6 g, 388 mmol) (216 mL) was added within 3 min, during which the maximum internal temperature was 6 °C. Solid 1-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)methyl)piperazine (66.3 g, 259 mmol) was then added over 1 min. The mixture was slowly warmed to room temperature and stirred for 15 hours. After addition of water (200 mL), the toluene layer was separated and extracted with 1.8 M aqueous HCl (600 mL). The aqueous phase was washed with toluene (2 x 300 mL). Methanol (500 mL) was added to the aqueous layer and the solution was cooled to 5°C. The pH was adjusted to 8-9 by dropwise addition of 50 wt% NaOH solution (~50 mL) and the internal temperature was controlled not to exceed 17°C. The resulting suspension was stirred at 5 °C for 2 h. The product was collected by filtration and washed with MeOH/H2O (1:1, 70 mL). The solid was dried in a vacuum oven at 50 °C for 24 h to afford N-(4-chloro-3-pyridinyl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]-1-piperazinecarboxamide as a yellow/green solid (73 g, 69% yield). To a 1L three-neck Morton flask equipped with a stir bar, thermocouple and reflux condenser was added the crude product, N-(4-chloro-3-pyridinyl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]-1-piperazinecarboxamide (98 g, 239 mmol) and isopropyl acetate (318 mL). The suspension was heated to 65 °C, activated carbon (10.0 g) was added and stirred at 65 °C for 1 hour. The mixture was then heated to 80°C and rapidly filtered through a diatomaceous earth pad. The filtrate was slowly cooled to room temperature and placed in an ice bath for 30 minutes. The solid was collected by filtration, washed with cold isopropyl acetate (10 mL) and dried to give the product (72 g, 73% yield). The crude product (191 g, 465 mmol) and isopropyl acetate (705 mL) were added to a 2 L three-neck Morton flask equipped with a mechanical stirrer, thermocouple and reflux condenser. The suspension was heated to 65 °C, activated carbon (11.2 g) was added and stirred at 65 °C for 1 hour. The mixture was then heated to 75°C and rapidly filtered. The filtrate was slowly cooled to room temperature overnight and then placed in an ice bath for 30 minutes. The solid was collected by filtration, washed with cold isopropyl acetate (40 mL) and dried in a vacuum oven at 50 °C for 72 h to give a light yellow solid product (161 g, 84% yield). MS (ESI+): m/z calculated for C18H17ClF2N4O3 [M+H]+ 411.1, found 411.1. Elemental analysis calculated for C18H17ClF2N4O3: C, 52.63; H, 4.17; N, 13.64. Found: C, 52.73; H, 4.15; N, 13.62. 1H NMR (600 MHz, CDCl3) δ: 9.36 (s, 1H), 8.19 (d, J = 5.2 Hz, 1H), 7.29 (dd, J = 5.3, 0.3 Hz, 1H), 7.13 (d, J = 0.9 Hz, 1H), 7.02- 6.98 (m, 5H), 6.84 (s, 1H), 3.58-3.54 (m, 4H), 3.53 (s, 2H), 2.54-2.48 (m, 4H); 13C NMR (151 MHz, CDCl3) δ: 153.49, 144.02, 143.88, 143.28, 142.98, 134.05, 133.09, 131.05 133.09, 131.66 (t, JC-F = 254.6 Hz), 131.55, 123.89, 123.53, 110.03, 109.02, 62.28, 52.47, 44.23.
in vitro
jnj-42165279 inhibited recombinant human and rat faah with the ic50s of 70 ± 8 nm and 313 ± 28 nm, respectively [1]. jnj-42165279 (10 μm) exhibited high selectivity against a panel of receptors, enzymes, transporters, and ion-channels. jnj-42165279 (10 μm) showed no inhibitory effects against cyps (1a2, 2c8, 2c9, 2c19, 2d6, 3a4) or herg [1].
in vivo
in the rat spinal nerve ligation (snl or chung) model of neuropathic pain, jnj-42165279 exhibited analgesic properties. jnj-42165279 dose-dependently reversed the robust tactile allodynia. the ed90 was 22 mg/kg, which corresponds to a plasma concentration of 2.5 μm at 30 min [1].
References
[1] keith j m, jones w m, tichenor m, et al. preclinical characterization of the faah inhibitor jnj-42165279[j]. acs medicinal chemistry letters, 2015, 6(12): 1204-1208.
N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Boyle Chemical Co., Ltd. | sales@boylechem.com | China | 2915 | 55 | |
| Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7545 | 61 |
| MedChemexpress LLC | 021-58955995 | sales@medchemexpress.cn | United States | 4853 | 58 |
| Taizhou Tongxin Bio-Tech Co., Ltd | 0523-86818997 18652728585 | sales@allyrise.com | China | 2993 | 60 |
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696，15000506266 15000506266 | China | 4858 | 55 | |
| Shanghaizehan biopharma technology co., Ltd. | 021-61350663 13052117465 | sales@zehanbiopharma.com | China | 989 | 55 |
| Shanghai Synchem Pharma Co., ltd | 21-619849051-1 18521059765 | synchempharma@aliyun.com | China | 4988 | 55 |
| Taizhou Ruixin Chemical Co., Ltd. | 0576-89085261 15867635987 | jasonhu09@163.com | China | 439 | 50 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| Tianjin Kailiqi Biotechnology Co., Ltd. | 15076683720 | klq@cw-bio.com | China | 9778 | 55 |
View Latest Price from N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-07-17 | JNJ-42165279
1346528-50-4
|
$38.00-88.00 | 99.91% | 10g | TargetMol Chemicals Inc. | ||
![N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide pictures](https://img.chemicalbook.com/ProductImageEN/2020-2/Small/107caff8-317d-4fcb-8483-cf6f173d2d5f.jpg) |
2020-02-06 | N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide
1346528-50-4
|
$3.00 | 1KG | 98% | 100KG | Career Henan Chemical Co |
-
- JNJ-42165279
1346528-50-4
- $38.00-88.00
- 99.91%
- TargetMol Chemicals Inc.
-
- N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide
1346528-50-4
- $3.00
- 98%
- Career Henan Chemical Co
